All Pharma articles
See all articles with this subject.
-
HSJ PartnersBehind every prescription is a person: reframing medicines optimisation for patient-centric impact in the NHS
Aspire Pharma Ltd initiated and funded this article but had no input into the content and was able to review it in advance of publication for factual accuracy and compliance checks only. Within the NHS, medicines are still too often discussed through the narrow lens of cost. Budgets ...
-
CommentPharma is working to boost drug availability, not prices
Victoria Jordan, director of value and access policy at the Association of the British Pharmaceutical Industry (ABPI), explores how medicine pricing affects patient access, research investment, and the sustainability of the UK health system
-
HSJ PartnersTransforming obesity care: how medicines optimisation can deliver sustainable outcomes
Obesity is one of the greatest public health challenges we face today, with more than a quarter of adults in England living with obesity, and the consequences – ranging from type 2 diabetes and cardiovascular disease to musculoskeletal problems and certain cancers – placing immense strain on both patients and ...
-
HSJ PartnersDigital transformation in the NHS: Navigating strategic shifts through system-wide coordination
The NHS 10-Year Health Plan, released in July 2025, establishes three fundamental shifts: analogue to digital, treatment to prevention, and hospital to community care.
-
CommentCompetition between GPs and pharmacies is hampering service integration
Community pharmacies are vital to NHS reforms, but funding, workforce, collaboration and digital barriers threaten their expanded role, write RAND Europe’s Robert J. Romanelli, Saoirse Moriarty and Maggie Bradford
-
NewsAnnual bill for NHS’s most costly drug set to be slashed
The annual cost of NHS diabetes care could fall by £300m after the Supreme Court refused to consider blocking the introduction of a generic alternative to a widely used drug.
-
NewsRevealed: Court battle over drug costing NHS £300m a year
The UK’s leading pharmaceutical firm has said it will have to cancel projects aiming to help thousands of NHS patients if it loses a legal case that would bring cheaper alternatives on to the market.
-
HSJ PartnersBridging the gap in hereditary angioedema care
As clinicians and patient representatives, we see firsthand the challenges faced by people living with hereditary angioedema, write Patrick Yong, Tomaz Garcez, Anthony Dorr, Emily Carne, and Angela Metcalfe
-
NewsEx-No 10 and NHSE advisers join same firm
One of the country’s leading decision-makers on cancer drugs and a former Downing Street health adviser have taken up new roles at a consultancy firm.
-
Expert BriefingPatient Safety Watch: NHS plan sets out bold new patient safety agenda
HSJ hosts the Patient Safety Watch newsletter, written by Patient Safety Watch chief executive James Titcombe
-
CommentThe environmental cost of medicines waste
Despite costing the NHS hundreds of millions of pounds annually, medicines waste remains largely invisible and unmeasured
-
NewsExclusive: NICE to remove approval from scores of drugs for first time
The National Institute for Health and Care Excellence will withdraw its backing for a large number of drugs and other interventions which now offer poor value for money in an unprecedented move set to be revealed in tomorrow’s 10-Year Health Plan, HSJ has learned.
-
HSJ AwardsHSJ Digital Awards 2025: Improving Medicines Management and Pharmacy Through Digital
WINNER Somerset Foundation Trust: Successful Integration of the Better Meds ePMA and Electronic Prescribing Service Into the Somerset Integrated Digital e-Record System
-
NewsICBs shouldn’t offload functions ‘overnight’, says NHSE director
The vast majority of trusts are “not ready” to take on primary care and neighbourhood functions, one of NHS England’s medical directors has said.
-
NewsWe’re ‘fundamental’ to future ICBs, say pharmacists
Medicines management teams should not be targeted by imminent cost cuts and must remain a “fundamental component” of the new model for integrated care boards, NHS England has been told.
-
NewsPharma chief to chair trust
High-flyers from the pharma and retail sectors have been appointed to chair two NHS trusts.
-
HSJ PartnersHome alone: Remote medication monitoring improves adherence and patient safety
People with mental health issues living at home need constant medication management
-
Expert BriefingPatient Safety Watch: The end of an era
HSJ hosts the Patient Safety Watch newsletter, written by Patient Safety Watch chief executive James Titcombe
-
HSJ PartnersCould medication adherence monitoring help bring together the NHS and social care sectors?
“The UK is experiencing increased demand for NHS and social care services. An increasing number of people are living longer with multiple long-term health conditions, and require support from a wide range of services at home, in the community and in hospitals.”
-
Expert BriefingImPatient: Influencing change
Patient (Lived Experience) Leadership is about those affected by life-changing illness, injury or disability who want to influence change through being equal partners in decision-making. In this monthly expert briefing, patient leadership champion David Gilbert picks out the most significant developments in a field of increasing relevance to the NHS.